| Sep 8, 2026 | Ryan Cohlhepp | PRESIDENT, COO & INTERIM CEO | SELL-OPTIONS | — | $13.34 | $334K |
| Aug 10, 2026 | Ivan Hyep | CHIEF FINANCIAL OFFICER | SELL-OPTIONS | — | $15.88 | $302K |
| Aug 10, 2026 | Claire Mazumdar | CHIEF EXECUTIVE OFFICER | SELL-OPTIONS | — | $15.88 | $242K |
| Aug 10, 2026 | Ryan Cohlhepp | PRESIDENT AND COO | SELL-OPTIONS | — | $15.88 | $453K |
| Jul 10, 2026 | Claire Mazumdar | CHIEF EXECUTIVE OFFICER | SELL-OPTIONS | — | $16.10 | $246K |
| Jul 8, 2026 | Ryan Cohlhepp | PRESIDENT AND COO | SELL | 10.000K | $16.38 | $762K |
| Jul 8, 2026 | Ivan Hyep | CHIEF FINANCIAL OFFICER | SELL | 15.500K | $16.32 | $760K |
| May 21, 2026 | Ivan Hyep | CHIEF FINANCIAL OFFICER | SELL-OPTIONS | — | $12.11 | $153K |
| May 18, 2026 | Claire Mazumdar | CHIEF EXECUTIVE OFFICER | SELL-OPTIONS | — | $11.91 | $244K |
| May 15, 2026 | Ryan Cohlhepp | PRESIDENT AND COO | SELL | 4.500K | $12.04 | $223K |
| Apr 27, 2026 | David Raben | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $13.33 | $105K |
